MDA5 Enhances Invasive Candida albicans Infection by Regulating Macrophage Apoptosis and Phagocytosis/Killing

Yayun Chen1,2, Qian Jiang1,3, Furong Qing4

  • 1School of Graduate, China Medical University, Shenyang, Liaoning, China.

Inflammation
|September 23, 2023
PubMed

Insights

The MDA5 immune receptor increases susceptibility to Candida albicans by promoting apoptosis and impairing macrophage function. This suggests MDA5 could be a therapeutic target for candidiasis.

Area of Science:

  • Immunology
  • Mycology
  • Molecular Biology

Background:

  • Candida albicans is an opportunistic pathogen.
  • The innate immune system defends against fungal infections.
  • MDA5 (Melanoma Differentiation-Associated protein 5) is an innate immune receptor involved in antiviral and anti-Aspergillus immunity.

Purpose of the Study:

  • To investigate the role of MDA5 in Candida albicans infection.
  • To elucidate the mechanisms by which MDA5 influences host defense against C. albicans.

Main Methods:

  • Human bioinformatics analysis and mouse experiments were used to assess IFIH1 gene expression.
  • In vivo studies evaluated host susceptibility in Ifih1 knockout mice.
  • Mechanisms were explored by analyzing apoptosis-related genes (Noxa, Bcl2, Bax) and macrophage function markers (iNOS).

Main Results:

  • IFIH1 gene expression increased in immune cells upon C. albicans stimulation.
  • MDA5 enhanced susceptibility to C. albicans infection independently of interferon production.
  • MDA5 promoted apoptosis in macrophages and kidneys by modulating Noxa, Bcl2, and Bax.
  • MDA5 inhibited macrophage killing capacity by suppressing iNOS expression.
  • Administration of an apoptosis inducer mimicked MDA5's effect, and macrophage scavengers increased susceptibility in Ifih1 knockout mice.

Conclusions:

  • MDA5 promotes host susceptibility to invasive Candida albicans infections.
  • MDA5 exerts its effects by enhancing cell apoptosis and compromising macrophage functions.
  • MDA5 represents a potential therapeutic target for treating candidiasis.